Oyster Point Pharma's Series A Round

Oyster Point Pharma raised a round of funding on October 25, 2017.

Oyster Point Pharma is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat ocular surface disease.…

Articles about Oyster Point Pharma's Series A Round: